High throughput biomarker discovery technologies generate massive amounts of data, but
rapid discovery requires more than just analytical speed. That is why we’ve built an expert
data science team to interpret these large-scale datasets for actionable insight.
Sapient provides you with advanced biocomputational support for:
This allow us to identify key biomarkers of interest and map both their genotype and phenotype associations related to:
Sapient’s Human Biology Database is comprised of data from >100,000 biosamples already run on our mass spectrometry platform. The samples represent diverse individuals and disease areas, and are paired with longitudinal data including adjudicated clinical outcomes spanning 10-30 years.
The database allows us to:
We build our biocomputational approach around your context of use, working collaboratively with your team to define experiments that give you the data you need for the phase you’re in. This could include analysis of biomarkers that inform:
Identify differentially expressed, disease-modifying, and tractable therapeutic targets that can be acted upon by your drug.